| 货号 | VK665026 |
|---|---|
| 品牌 | abinScience |
| 种属反应性 | Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5) |
| 应用 | Research Grade Biosimilar |
| 宿主 | Human |
| 同种型 | IgG1, lambda2 |
| 表达系统 | Mammalian Cells |
| 克隆类型 | Monoclonal |
| 靶标 | Envelope glycoprotein B, gB, UL55 |
| 内毒素水平 | Please contact the lab for this information. |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G, purified from cell culture supernatant. |
| Accession号 | P06473 |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS,pH7.4. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 别名 | NPC21,NPC-21,NPC21,CAS:2467411-25-0 |
| 背景 | Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMV envelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
027-87433958/17302791434
武汉东湖新技术开发区神墩四路666号研发楼B区3层东
